This proteomics-driven approach to drug discovery improves target validation and uncovers insights into undruggable proteins, ...

Creative Biolabs is accelerating gene therapy research globally with specialized expertise. SHIRLEY, NY, UNITED STATES, ...

A study shows that specific plant-derived compounds work synergistically in immune cells, boosting anti-inflammatory ...

Mitochondria possess their own mRNA translation system, mediated by specialized mitoribosomes. Dysregulation of mitochondrial translation disrupts metabolic homeostasis and is linked to various ...

The cell-free protein synthesis (CFPS) market is set to reach USD 308.9 million by 2030, growing at a CAGR of 7.3%. Key growth drivers include rising demand for rapid protein production, adoption of ...

Our brains age along with the rest of our bodies, and as they do, they produce fewer new brain cells. Now, researchers have ...

New data from a phase 1b/2 clinical trial shows that a specific protein called CD47 can help predict how well the investigational drug evorpacept works for patients with metastatic breast cancer, ALX ...

A newly identified protein may hold the key to rejuvenating aging brain cells. Researchers found that boosting DMTF1 can ...

The proteomics market is experiencing strong growth as demand rises for advanced tools that analyze protein structure, ...

Many everyday foods and seasonings—such as herbs, spices, and aromatic plants—contain natural compounds called phytochemicals that can regulate inflammatory pathways. For centuries, these ingredients ...

Krystal is leveraging a validated, redosable platform with high margins, profitability, and multiple blockbuster catalysts in CF and NK. Read why KRYS is a Buy.